Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster
  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Markets trade on a choppy note
Tue, 8 Sep 11:30 am

After opening the day on a dull note, the Indian Indices are currently trading marginally higher. Sectoral indices are trading on a mixed note with FMCG and pharma stocks leading the losers. However, energy stocks are trading in the green.

The BSE-Sensex is trading up 59 points (up 0.2%) and the NSE-Nifty is trading up by 9 points (up 0.1%). The S&P BSE Midcap index is trading down by 0.7% and the S&P BSE Smallcap index is trading down by 1.2%. The rupee is trading at 66.73 to the US dollar.

Stocks in the automobile space are trading on a mixed note with Eicher Motors and Escorts leading the losses. As per an article in Economic Times, auto major Mahindra & Mahindra (M&M) is looking to enhance its market share in the utility vehicle segment with the upcoming compact SUV, TUV 300. The company will launch the TUV300 this week, which will be available only as diesel option and is expected to be priced around Rs 7-9 lakh. For the April-July period this fiscal, total utility vehicle sales for M&M stood at 62,558 units, translating into a market share of 36.1%. Presently the stock of M&M is trading up by 0.7%.

Pharma stocks are trading on a discouraging note with Dishman Pharma and Elder Pharma bearing the maximum burnt. As per a leading financial daily, the Reserve Bank of India (RBI) has allowed foreign institutional investors (FIIs) to buy up to 31.5% of the paid up capital of Natco Pharma. Earlier the FII limit in the company was 24%. The company has passed resolutions at its board of directors' level and a special resolution by the shareholders. These were passed in order to seek agreement on enhancing the limit for the purchase of its equity shares and convertible debentures by FIIs. Scrip of Natco Pharma is trading down by 3.5% on the BSE.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Markets trade on a choppy note". Click here!


Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms


Jan 19, 2018 (Close)